Vera Therapeutics (VERA) Competitors $23.05 -0.71 (-2.99%) Closing price 04:00 PM EasternExtended Trading$23.04 0.00 (-0.02%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERA vs. TGTX, NUVL, LNTH, AXSM, TLX, CRSP, ADMA, RYTM, PCVX, and AKROShould you be buying Vera Therapeutics stock or one of its competitors? The main competitors of Vera Therapeutics include TG Therapeutics (TGTX), Nuvalent (NUVL), Lantheus (LNTH), Axsome Therapeutics (AXSM), Telix Pharmaceuticals (TLX), CRISPR Therapeutics (CRSP), ADMA Biologics (ADMA), Rhythm Pharmaceuticals (RYTM), Vaxcyte (PCVX), and Akero Therapeutics (AKRO). These companies are all part of the "pharmaceutical products" industry. Vera Therapeutics vs. Its Competitors TG Therapeutics Nuvalent Lantheus Axsome Therapeutics Telix Pharmaceuticals CRISPR Therapeutics ADMA Biologics Rhythm Pharmaceuticals Vaxcyte Akero Therapeutics Vera Therapeutics (NASDAQ:VERA) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment. Which has more risk & volatility, VERA or TGTX? Vera Therapeutics has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500. Do insiders & institutionals have more ownership in VERA or TGTX? 99.2% of Vera Therapeutics shares are owned by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are owned by institutional investors. 16.3% of Vera Therapeutics shares are owned by company insiders. Comparatively, 10.6% of TG Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger valuation and earnings, VERA or TGTX? TG Therapeutics has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVera TherapeuticsN/AN/A-$152.15M-$3.00-7.68TG Therapeutics$329M18.29$23.38M$0.24157.96 Do analysts rate VERA or TGTX? Vera Therapeutics currently has a consensus price target of $65.00, suggesting a potential upside of 182.00%. TG Therapeutics has a consensus price target of $43.80, suggesting a potential upside of 15.54%. Given Vera Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Vera Therapeutics is more favorable than TG Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.10TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Is VERA or TGTX more profitable? TG Therapeutics has a net margin of 10.13% compared to Vera Therapeutics' net margin of 0.00%. TG Therapeutics' return on equity of 18.88% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vera TherapeuticsN/A -40.59% -34.54% TG Therapeutics 10.13%18.88%7.05% Does the media refer more to VERA or TGTX? In the previous week, TG Therapeutics had 4 more articles in the media than Vera Therapeutics. MarketBeat recorded 7 mentions for TG Therapeutics and 3 mentions for Vera Therapeutics. TG Therapeutics' average media sentiment score of 0.95 beat Vera Therapeutics' score of 0.65 indicating that TG Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vera Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TG Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTG Therapeutics beats Vera Therapeutics on 10 of the 16 factors compared between the two stocks. Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERA vs. The Competition Export to ExcelMetricVera TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.52B$2.96B$5.54B$9.41BDividend YieldN/A2.46%3.75%4.03%P/E Ratio-7.688.2821.0120.09Price / SalesN/A303.17433.8199.01Price / CashN/A42.5936.1658.27Price / Book2.547.678.125.65Net Income-$152.15M-$55.28M$3.25B$257.91M7 Day Performance-3.23%2.50%0.97%2.09%1 Month Performance10.18%11.70%7.36%11.13%1 Year Performance-33.80%4.89%31.31%18.40% Vera Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERAVera Therapeutics4.1061 of 5 stars$23.05-3.0%$65.00+182.0%-32.5%$1.52BN/A-7.6840TGTXTG Therapeutics3.4049 of 5 stars$35.98-2.0%$40.80+13.4%+77.5%$5.71B$329M149.92290NUVLNuvalent3.1882 of 5 stars$77.93-3.2%$119.60+53.5%+6.4%$5.60BN/A-17.7540Insider TradeLNTHLantheus4.6282 of 5 stars$79.19-1.5%$130.50+64.8%-39.5%$5.48B$1.53B22.50700News CoveragePositive NewsAnalyst ForecastAXSMAxsome Therapeutics4.7309 of 5 stars$107.50+2.0%$172.33+60.3%+34.0%$5.29B$385.69M-18.63380Analyst RevisionTLXTelix PharmaceuticalsN/A$15.48-3.7%$22.33+44.3%N/A$5.24B$783.21M0.00N/AAnalyst RevisionCRSPCRISPR Therapeutics2.69 of 5 stars$51.19-1.9%$71.75+40.2%-8.9%$4.42B$37.31M-11.33460Insider TradeAnalyst RevisionGap UpADMAADMA Biologics3.8794 of 5 stars$17.88-2.2%$27.67+54.7%+32.4%$4.27B$426.45M21.04530Positive NewsRYTMRhythm Pharmaceuticals3.1928 of 5 stars$66.39+0.9%$78.07+17.6%+74.1%$4.22B$130.13M-23.63140Analyst ForecastAnalyst RevisionPCVXVaxcyte1.8072 of 5 stars$32.00-3.8%$136.50+326.6%-54.1%$4.13BN/A-8.02160Positive NewsAKROAkero Therapeutics3.6862 of 5 stars$51.52-0.5%$82.50+60.1%+100.6%$4.11BN/A-26.4230Positive NewsInsider Trade Related Companies and Tools Related Companies TG Therapeutics Competitors Nuvalent Competitors Lantheus Competitors Axsome Therapeutics Competitors Telix Pharmaceuticals Competitors CRISPR Therapeutics Competitors ADMA Biologics Competitors Rhythm Pharmaceuticals Competitors Vaxcyte Competitors Akero Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERA) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERA Stock Alerts